Net revenues (Tables)

12 Months Ended

Dec. 31, 2022

Revenue from Contract with Customer [Abstract]

Disaggregation of Revenue

The following table disaggregates revenue by global product category for the year ended December 31, 2022, 2021 and 2020.

	Year Ended December 31,
	2022		2021		2020
Vascular access	$	683,612	$	700,240	$	657,703
Anesthesia	388,890		380,140		302,293
Interventional	445,018		427,500		382,435
Surgical	392,917		377,756		317,200
Interventional urology	322,832		341,661		290,022
OEM	272,624		245,681		220,246
Other (1)	285,148		336,585		367,257
Net revenues (2)	$	2,791,041	$	2,809,563	$	2,537,156

(1) Includes revenues generated from sales of our respiratory and urology products (other than interventional urology products). Certain product lines within the respiratory product category were sold during 2021. See Note 4 for additional information related to the Respiratory business divestiture.

(2) The product categories listed above are presented on a global basis, while each of our reportable segments other than the OEM reportable segment are defined based on the geographic location of its operations; the OEM reportable segment operates globally. Each of the geographically based reportable segments includes net revenues from each of the non-OEM product categories listed above.